BREAKING: Futures Jump On Megacap Tech Earnings Amgen reported second-quarter sales late Tuesday that merely met Wall Street expectations as the giant drugmaker also maintained its revenue guidance for the year."The pandemic interrupted many physician-patient interactions, which led to delays in diagnosis and treatment with varying degrees of impact across our portfolio," Amgen said in its release.